MYCN and neuroblastoma: However, a number of miRNAs have been found to directly target MYCN and inhibit NB cell proliferation, such as miRNA let-7e, miR-202, miR-375 and miR-204 [96–98], suggesting that overexpression of these miRNAs may provide a novel therapeutic strategy for MYCN-amplified NB.